Osaic Holdings
INTS icon

Osaic Holdings’s Intensity Therapeutics INTS Stock Holding History

Osaic Holdings’s Portfolio INTS Stock Details INTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$820 Hold
200
– – ﹤0.01% 7539
2026
Q1 		$1.18K Buy
+200
New +$1.63K ﹤0.01% 7216
2024
Q1 		– Sell
-160
Closed -$34.3K – 7298
2023
Q4 		$34.3K Buy
160
+80
+100% +$8.42K ﹤0.01% 5139
2023
Q3 		$7.94K Buy
+80
New +$11.1K ﹤0.01% 6059

Other funds holding INTS

KCIA
Kingsbury Capital Investment Advisors Wilmette, Illinois $118M AUM
KWM
KMT Wealth Management El Segundo, California $118M AUM 26.19% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.25B AUM 22.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SC
Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
MFIM
Mesirow Financial Investment Management Chicago, Illinois $6.37B AUM 23.22% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Osaic Holdings's INTS Position: Q2 2026 in Review

Osaic Holdings held its Intensity Therapeutics (INTS) position steady in Q2 2026 at 200 shares worth $820. The position accounts for ﹤0.01% of the portfolio, ranked #7539.

Osaic Holdings first reported a position in INTS in Q3 2023 and has held it in 4 quarters since. The position peaked at $34.3K in Q4 2023. 17 funds tracked by Wall St. Rank hold INTS as of Q2 2026.

  • Osaic Holdings held 200 shares of Intensity Therapeutics worth $820 as of Q2 2026.
  • Osaic Holdings left its Intensity Therapeutics share count unchanged in Q2 2026.
  • Intensity Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7539 holding.
  • Osaic Holdings first reported a position in Intensity Therapeutics in Q3 2023 and has held it in 4 quarters since.
  • Osaic Holdings's Intensity Therapeutics position peaked at $34.3K in Q4 2023.
  • 17 funds tracked by Wall St. Rank held Intensity Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.